Plenary Session

385 Folgen

1. 2.56 HER2CLIMB & Misinformation and Disinformation with Dr. Cailin O'Connor

   Vom: 12.6.2020
2. 2.55 Hydroxychloroquine for COVID-19, ASCO, QOTW, Private Equity in Medicine with Dr. Jane Zhu

   Vom: 5.6.2020
3. 2.54 Classical Hematology Chat on Thrombosis in COVID-19 & Drugs for COVID-19 with Dr. Walid Gellad

   Vom: 31.5.2020
4. 2.53 Why Agreeing 65% with Someone is Important & COVID-19 Health Policy with Dr. Daniel Morgan

   Vom: 23.5.2020
5. 2.52 Malignant Audiobook, PROfound trial, & Literature and Medicine with Dr. Adam Cifu

   Vom: 16.5.2020
6. 2.51 BONUS! Clinical Trials Part 3

   Vom: 13.5.2020
7. 2.50 Neil Ferguson, Ending Lockdown, & Updates on COVID-19 Management with Dr. Benjamin Singer

   Vom: 7.5.2020
8. 2.49 COVID-19 Contrarians, Remdesivir, & Book Club on "Malignant" with OHSU HemOnc Fellows

   Vom: 2.5.2020
9. 2.48 BONUS! Introduction to Malignant: How Bad Policy and Bad Evidence Harm People with Cancer

   Vom: 25.4.2020
10. 2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari

    Vom: 16.4.2020
11. 2.46 Psychology Unearthed by COVID-19 Precautions & Polygenic Risk Score with Dr. Venk Murthy

    Vom: 11.4.2020
12. 2.45 Viral Spread of SARS-CoV-2, Rationing Resources, "Evidence Fiasco", & Classical Hematology Chat

    Vom: 1.4.2020
13. 2.44 ICU Management of COVID-19 with Dr. Benjamin Singer

    Vom: 25.3.2020
14. 2.43 BONUS! Novel Coronavirus and the COVID-19 Response in Oregon with Dr. John Townes

    Vom: 18.3.2020
15. 2.42 Quality-of-Life Measurement in Oncology, KnowYourTumor, & Question of the Week

    Vom: 17.3.2020
16. 2.41 BONUS! Clinical Trials Part 2: Crossover and Control Arms

    Vom: 11.3.2020
17. 2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr

    Vom: 5.3.2020
18. 2.39 Effectiveness of Newer-Generation Antidepressants with Dr. Michael Hengartner

    Vom: 27.2.2020
19. 2.38 KEYNOTE-048, Academic Currency, & Trials in Low/Mid-Income Countries with Dr. Bishal Gyawali

    Vom: 19.2.2020
20. 2.37 Careerism, Presenting Abstracts, Twitter and the K-Index, & Classical Hematology Chat

    Vom: 14.2.2020